P3: Review of Neurofeedback in Epilepsy
Authors
Abstract:
This article doesn't have abstract
similar resources
Neurofeedback treatment of epilepsy.
With electroencephalographic (EEG) biofeedback (or neurofeedback), it is possible to train the brain to de-emphasize rhythms that lead to generation and propagation of seizure and emphasize rhythms that make seizures less likely to occur. With recent improvements in quantitative EEG measurement and improved neurofeedback protocols, it has become possible in clinical practice to eliminate seizur...
full textLong Term Effects of Neurofeedback In ADHD and Epilepsy
s and titles of invited lectures will be announced a.s.a.p. April 14, 2010 Evening program 17:00-17:30 Welcome party with snacks and drinks 17:30-18:00 Official opening Welcome by Erik Peper (President BFE) & Monika Fuhs (Executive Director BFE) Welcome by Prof dr. Giuseppe Sacco 18:00-20:00 Invited lectures Ute Strehl: “long term effects of neurofeedback in ADHD and epilepsy” Sue Wilson: “ Bio...
full textFoundation and practice of neurofeedback for the treatment of epilepsy.
This review provides an updated overview of the neurophysiological rationale, basic and clinical research literature, and current methods of practice pertaining to clinical neurofeedback. It is based on documented findings, rational theory, and the research and clinical experience of the authors. While considering general issues of physiology, learning principles, and methodology, it focuses on...
full textA review on the most valuable biomarkers in epilepsy
Background & Objective: Epilepsy is a common neurological disorder with the prevalence of 50 million in the world. Despite of many researches and introducing of different anti-epileptic drugs, 30% of patients suffer from refractory seizures. Biomarkers are the measurable indicators to detect the physiological and pathological condition. Biomarkers in epilepsy can be utilized for prediction, dia...
full textP 145: A Review of Animal Models of Absence Epilepsy
The most common type of childhood-onset epilepsy syndrome is childhood absence epilepsy (CAE) with well-defined electro clinical features but unknown pathological basis. The incidence of absence epilepsy is about 2 and 8 out of every 100 000 children up to the age of 16, and the prevalence is 2 and 10% of children with any form of epilepsy. Children with CAE suffer from high rate of pretreatmen...
full textMy Resources
Journal title
volume 6 issue 3
pages 30- 30
publication date 2018-07
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023